Results 81 to 90 of about 28,600 (213)
Of mice and men—The emerging oral–gut–brain axis of health and disease
Periodontology 2000, EarlyView.Abstract Objectives Oral health's inextricable links to systemic health are highlighted by the emerging oral–gut–brain axis and other well‐known axes. There is growing evidence of a complex oral–gut–brain axis linking mouth and gut microbiomes with the central nervous system.
Yvonne L. Hernandez‐Kapila +1 more
wiley +1 more source
Digital and Biomarker‐Based Monitoring for Schizophrenia‐Treatment Adherence
Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.Monitoring technologies integrated with artificial intelligence can enable personalized care, improved adherence, and reduced relapses among psychotic patients. ABSTRACT Background Nonadherence to antipsychotics affects nearly half of patients with schizophrenia, leading to rehospitalization, suicidality, and reduced quality of life.
Samuel Inshutiyimana +5 more
wiley +1 more source
Neuropsychiatric Disease and Treatment, 2008 Takahiko NagamineDivision of Psychiatric Internal Medicine, Seiwakai-Kitsunan Hospital, Suzenji, JapanAbstract: Second generation antipsychotics are associated with the risk of metabolic disorders such as diabetes mellitus and hyperlipidemia.
Takahiko Nagamine
doaj
Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.A case of multiple sclerosis detected by brain MRI during evaluation for modified electroconvulsive therapy in the long‐term course of schizophrenia. This case discusses the clinical overlap between multiple sclerosis pathology and treatment‐resistant schizophrenia. ABSTRACT Multiple sclerosis (MS) can present with neurological and psychiatric symptoms
Sho Miura +10 more
wiley +1 more source
Olanzapine: Are Extrapyramidal Symptoms as Rare as We Think? – A Case Series
Archives of Medicine and Health SciencesOlanzapine, a second-generation antipsychotic has proven to be very efficacious with a low probability of extrapyramidal symptoms (EPS). Here, we wish to report a series of cases where EPS is occurring as a rare side effect due to olanzapine.
Akansha Bhardwaj +3 more
doaj +1 more source
What Matters Most: A Case of Pemphigus Vulgaris in a Nonagenarian Physician
Journal of the American Geriatrics Society, EarlyView.
Svetlana Bagdasarov +6 more
wiley +1 more source
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.Abstract Background Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is an immunotherapy‐responsive inflammatory central nervous system disorder. Psychiatric manifestations include delirium, cognitive or behavioral change, apathy, depressive symptoms, and anxiety; however, frank delusional psychosis before corticosteroid exposure is ...
Tomomi Sugisaki +6 more
wiley +1 more source
Future Journal of Pharmaceutical SciencesBackground Samidorphan is an opioid antagonist while Olanzapine is an effective medication for schizophrenia and bipolar disorder. A unique and accurate MS/HPLC approach due to simultaneous measurement of Olanzapine and Samidorphan is, therefore, more ...
Rambabu Kantipudi +1 more
doaj +1 more source
A call for action: Closing the evidence gap in management of stimulant‐induced psychosis
Addiction, Volume 121, Issue 9, Page 2275-2283, September 2026.Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier +3 more
wiley +1 more source